Novo Biosciences Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4M

  • Investors
  • 4

Novo Biosciences General Information

Description

Developer of cardiac drugs designed to reverse the life-threatening damage caused by heart attacks. The company's drugs spur the body to heal by triggering self-repair and regrowth mechanisms that lie dormant in genes, enabling patients to regenerate damaged organs and tissues and live healthy lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • One City Hall Plaza
  • Ellsworth, ME 04605
  • United States
+1 (207) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novo Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 09-Jun-2020 $4M 00.000 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2020 0000 Completed Generating Revenue
4. Grant 07-Sep-2017 00.00 0000 Completed Generating Revenue
3. Accelerator/Incubator 0000 Completed Generating Revenue
2. Angel (individual) 16-Jul-2015 $75K $75K Completed Generating Revenue
1. Grant 17-Nov-2014 $25K Completed Generating Revenue
To view Novo Biosciences’s complete valuation and funding history, request access »

Novo Biosciences Executive Team (3)

Name Title Board Seat Contact Info
Viravuth Yin Ph.D Co-Founder, Board Member & Chief Scientific Officer
You’re viewing 1 of 3 executive team members. Get the full list »

Novo Biosciences Board Members (2)

Name Representing Role Since
Viravuth Yin Ph.D Novo Biosciences Co-Founder, Board Member & Chief Scientific Officer 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Novo Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novo Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
DRIVEN Accelerator Hub Accelerator/Incubator 000 0000 000000 0
National Heart, Lung, and Blood Institute Government 000 0000 000000 0
Maine Technology Institute Not-For-Profit Venture Capital 000 0000 000000 0
MDI BioSpace Incubator Accelerator/Incubator 000 0000 000000 0
To view Novo Biosciences’s complete investors history, request access »

Novo Biosciences FAQs

  • When was Novo Biosciences founded?

    Novo Biosciences was founded in 2013.

  • Who is the founder of Novo Biosciences?

    Kevin Strange Ph.D and Viravuth Yin Ph.D are the founders of Novo Biosciences.

  • Where is Novo Biosciences headquartered?

    Novo Biosciences is headquartered in Ellsworth, ME.

  • What is the size of Novo Biosciences?

    Novo Biosciences has 2 total employees.

  • What industry is Novo Biosciences in?

    Novo Biosciences’s primary industry is Drug Discovery.

  • Is Novo Biosciences a private or public company?

    Novo Biosciences is a Private company.

  • What is Novo Biosciences’s current revenue?

    The current revenue for Novo Biosciences is 000000.

  • How much funding has Novo Biosciences raised over time?

    Novo Biosciences has raised $4.08M.

  • Who are Novo Biosciences’s investors?

    DRIVEN Accelerator Hub, National Heart, Lung, and Blood Institute, Maine Technology Institute, and MDI BioSpace Incubator have invested in Novo Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »